Severance Hospital
Seoul, 120-752, South Korea
NCT Number: NCT01274130
This is the investigatory study to find out metformin's pharmacokinetics, pharmacodynamics and drug-drug interactions classifying the group by MATE1 genotype in healthy volunteers. The investigators will apply ranitidine and verapamil to the drug interaction study of metformin.
Looking for future studies?
Notify Me20 year–50 year
All sexes
Interventional
Not applicable
Seoul, 120-752, South Korea
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Diavex 1000mg on Day1 and 750mg on Day2
Other names: Diavex®
Yonsei University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05454007
Brain Diseases, Cardiovascular Diseases
Lebanon, Oregon, United States
View Trial DetailsNCT07717645
Alcohol Abstinence, Behavior
Mersin, Turkey (Türkiye)
View Trial DetailsNCT06818032
Healthy, Healthy Adult
Burlington, Vermont, United States
View Trial DetailsNCT07633691
Healthy Adult
Gangseo-gu, Seoul, South Korea
View Trial Details